These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28323288)

  • 1. Citalopram amplifies the influence of living conditions on mood in depressed patients enrolled in the STAR*D study.
    Chiarotti F; Viglione A; Giuliani A; Branchi I
    Transl Psychiatry; 2017 Mar; 7(3):e1066. PubMed ID: 28323288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting antidepressant treatment outcome based on socioeconomic status and citalopram dose.
    Viglione A; Chiarotti F; Poggini S; Giuliani A; Branchi I
    Pharmacogenomics J; 2019 Dec; 19(6):538-546. PubMed ID: 30723316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Income and attrition in the treatment of depression: a STAR*D report.
    Warden D; Rush AJ; Wisniewski SR; Lesser IM; Thase ME; Balasubramani GK; Shores-Wilson K; Nierenberg AA; Trivedi MH
    Depress Anxiety; 2009; 26(7):622-33. PubMed ID: 19582825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family history of depression and therapeutic outcome: findings from STAR*D.
    Husain MM; Rush AJ; Wisniewski SR; McClintock SM; Fava M; Nierenberg AA; Davis L; Balasubramani GK; Young E; Albala AA; Trivedi MH
    J Clin Psychiatry; 2009 Feb; 70(2):185-95. PubMed ID: 19192454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
    Trivedi MH; Rush AJ; Wisniewski SR; Nierenberg AA; Warden D; Ritz L; Norquist G; Howland RH; Lebowitz B; McGrath PJ; Shores-Wilson K; Biggs MM; Balasubramani GK; Fava M;
    Am J Psychiatry; 2006 Jan; 163(1):28-40. PubMed ID: 16390886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do menopausal status and use of hormone therapy affect antidepressant treatment response? Findings from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study.
    Kornstein SG; Toups M; Rush AJ; Wisniewski SR; Thase ME; Luther J; Warden D; Fava M; Trivedi MH
    J Womens Health (Larchmt); 2013 Feb; 22(2):121-31. PubMed ID: 23398127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report.
    McGrath PJ; Khan AY; Trivedi MH; Stewart JW; Morris DW; Wisniewski SR; Miyahara S; Nierenberg AA; Fava M; Rush AJ
    J Clin Psychiatry; 2008 Dec; 69(12):1847-55. PubMed ID: 19026268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive socioeconomic and clinical profiles of antidepressant response and remission.
    Jain FA; Hunter AM; Brooks JO; Leuchter AF
    Depress Anxiety; 2013 Jul; 30(7):624-30. PubMed ID: 23288666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic subgroups for citalopram response in the STAR*D trial.
    Jakubovski E; Bloch MH
    J Clin Psychiatry; 2014 Jul; 75(7):738-47. PubMed ID: 24912106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do atypical features affect outcome in depressed outpatients treated with citalopram?
    Stewart JW; McGrath PJ; Fava M; Wisniewski SR; Zisook S; Cook I; Nierenberg AA; Trivedi MH; Balasubramani GK; Warden D; Lesser I; John Rush A
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):15-30. PubMed ID: 19341509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression.
    Gyurak A; Patenaude B; Korgaonkar MS; Grieve SM; Williams LM; Etkin A
    Biol Psychiatry; 2016 Feb; 79(4):274-81. PubMed ID: 25891220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequenced Treatment Alternatives to Relieve Depression (STAR*D): lessons learned.
    Zisook S; Ganadjian K; Moutier C; Prather R; Rao S
    J Clin Psychiatry; 2008 Jul; 69(7):1184-5. PubMed ID: 18687018
    [No Abstract]   [Full Text] [Related]  

  • 13. Diurnal mood variation in outpatients with major depressive disorder.
    Morris DW; Trivedi MH; Fava M; Wisniewski SR; Balasubramani GK; Khan AY; Jain S; Rush AJ
    Depress Anxiety; 2009; 26(9):851-63. PubMed ID: 19306304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What are the treatment remission, response and extent of improvement rates after up to four trials of antidepressant therapies in real-world depressed patients? A reanalysis of the STAR*D study's patient-level data with fidelity to the original research protocol.
    Pigott HE; Kim T; Xu C; Kirsch I; Amsterdam J
    BMJ Open; 2023 Jul; 13(7):e063095. PubMed ID: 37491091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder.
    Cutler JA; Rush AJ; McMahon FJ; Laje G
    J Psychopharmacol; 2012 Mar; 26(3):360-7. PubMed ID: 22282879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report.
    Leuchter AF; Husain MM; Cook IA; Trivedi MH; Wisniewski SR; Gilmer WS; Luther JF; Fava M; Rush AJ
    Psychol Med; 2010 Feb; 40(2):239-51. PubMed ID: 19493369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexual satisfaction and quality of life in major depressive disorder before and after treatment with citalopram in the STAR*D study.
    Ishak WW; Christensen S; Sayer G; Ha K; Li N; Miller J; Nguyen JM; Cohen RM
    J Clin Psychiatry; 2013 Mar; 74(3):256-61. PubMed ID: 23561231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic-Pharmacodynamic interaction associated with venlafaxine-XR remission in patients with major depressive disorder with history of citalopram / escitalopram treatment failure.
    Ahmed AT; Biernacka JM; Jenkins G; Rush AJ; Shinozaki G; Veldic M; Kung S; Bobo WV; Hall-Flavin DK; Weinshilboum RM; Wang L; Frye MA
    J Affect Disord; 2019 Mar; 246():62-68. PubMed ID: 30578947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reevaluating the Efficacy and Predictability of Antidepressant Treatments: A Symptom Clustering Approach.
    Chekroud AM; Gueorguieva R; Krumholz HM; Trivedi MH; Krystal JH; McCarthy G
    JAMA Psychiatry; 2017 Apr; 74(4):370-378. PubMed ID: 28241180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute antidepressive efficacy of lithium monotherapy, not citalopram, depends on recurrent course of depression.
    Bschor T; Uhr M; Baethge C; Lewitzka U; Ising M; Erbe S; Winkelmann P; Ritter D
    J Clin Psychopharmacol; 2013 Feb; 33(1):38-44. PubMed ID: 23277245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.